GLENMEDE TRUST CO NA: PWV position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of GLENMEDE TRUST CO NA on PWV, newest first. How the timeline and the estimate are built.
GLENMEDE TRUST CO NA held 548 PWV shares at 2026-06-30 per its 13F-HR filed 2026-08-10.
the latest 13F is the newest step
- period ended2026-06-3013F 548 sharesChange vs previous 13F 0 shares
<0.01% of the 13F portfolio, value $41,521.
13F-HR 0001398344-26-013895 filed by GLENMEDE TRUST CO NA
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 548 sharesChange vs previous 13F 0 shares
<0.01% of the 13F portfolio, value $38,201.
13F-HR 0001398344-26-009724 filed by GLENMEDE TRUST CO NA
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 548 sharesChange vs previous 13F -1,360 shares
<0.01% of the 13F portfolio, value $36,452.
13F-HR 0001398344-26-003230 filed by GLENMEDE TRUST CO NA
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 1,908 sharesChange vs previous 13F +60 shares
<0.01% of the 13F portfolio, value $113,545.
13F-HR 0001398344-25-009609 filed by GLENMEDE TRUST CO NA
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F 1,848 sharesChange vs previous 13F 0 shares
<0.01% of the 13F portfolio, value $105,106.
13F-HR 0001398344-25-002875 filed by GLENMEDE TRUST CO NA
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-09-3013F 1,848 sharesChange vs previous 13F not available
<0.01% of the 13F portfolio, value $107,777.
13F-HR 0001398344-24-020665 filed by GLENMEDE TRUST CO NA
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).